Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and raises the price ...
Orthofix Medical (NASDAQ:OFIX) narrows FY2025 sales outlook from $808.000 million-$816.000 million to $810.000 million-$814.000...
Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $(0....
Stifel analyst Thomas Stephan reinstates Orthofix Medical (NASDAQ:OFIX) with a Buy and announces $22 price target.
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and maintains $17 pri...
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a ...
Orthofix Medical (NASDAQ:OFIX) affirms FY2025 sales outlook from $808.000 million-$816.000 million to $808.000 million-$816.000...
